Impact of STEADI-Rx : A Community Pharmacy-Based Fall Prevention Intervention
© 2020 The American Geriatrics Society..
OBJECTIVES: To evaluate the effects of a community pharmacy-based fall prevention intervention (STEADI-Rx) on the risk of falling and use of medications associated with an increased risk of falling.
DESIGN: Randomized controlled trial.
SETTING: A total of 65 community pharmacies in North Carolina (NC).
PARTICIPANTS: Adults (age ≥65 years) using either four or more chronic medications or one or more medications associated with an increased risk of falling (n = 10,565).
INTERVENTION: Pharmacy staff screened patients for fall risk using questions from the Stopping Elderly Accidents, Deaths, and Injuries (STEADI) algorithm. Patients who screened positive were eligible to receive a pharmacist-conducted medication review, with recommendations sent to patients' healthcare providers following the review.
MEASUREMENTS: At intervention pharmacies, pharmacy staff used standardized forms to record participant responses to screening questions and information concerning the medication reviews. For participants with continuous Medicare Part D/NC Medicaid coverage (n = 3,212), the Drug Burden Index (DBI) was used to assess exposure to high-risk medications, and insurance claims records for emergency department visits and hospitalizations were used to assess falls.
RESULTS: Among intervention group participants (n = 4,719), 73% (n = 3,437) were screened for fall risk. Among those who screened positive (n = 1,901), 72% (n = 1,373) received a medication review; and 27% (n = 521) had at least one medication-related recommendation communicated to their healthcare provider(s) following the review. A total of 716 specific medication recommendations were made. DBI scores decreased from the pre- to postintervention period in both the control and the intervention group. However, the amount of change over time did not differ between these two groups (P = .66). Risk of falling did not change between the pre- to postintervention period or differ between groups (P = .58).
CONCLUSION: We successfully implemented STEADI-Rx in the community pharmacy setting. However, we found no differences in fall risk or the use of medications associated with increased risk of falling between the intervention and control groups. J Am Geriatr Soc 68:1778-1786, 2020.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:68 |
---|---|
Enthalten in: |
Journal of the American Geriatrics Society - 68(2020), 8 vom: 21. Aug., Seite 1778-1786 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Blalock, Susan J [VerfasserIn] |
---|
Links: |
---|
Themen: |
Aging |
---|
Anmerkungen: |
Date Completed 02.03.2021 Date Revised 02.03.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/jgs.16459 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM308998901 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM308998901 | ||
003 | DE-627 | ||
005 | 20231225132939.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/jgs.16459 |2 doi | |
028 | 5 | 2 | |a pubmed24n1029.xml |
035 | |a (DE-627)NLM308998901 | ||
035 | |a (NLM)32315461 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Blalock, Susan J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of STEADI-Rx |b A Community Pharmacy-Based Fall Prevention Intervention |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.03.2021 | ||
500 | |a Date Revised 02.03.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 The American Geriatrics Society. | ||
520 | |a OBJECTIVES: To evaluate the effects of a community pharmacy-based fall prevention intervention (STEADI-Rx) on the risk of falling and use of medications associated with an increased risk of falling | ||
520 | |a DESIGN: Randomized controlled trial | ||
520 | |a SETTING: A total of 65 community pharmacies in North Carolina (NC) | ||
520 | |a PARTICIPANTS: Adults (age ≥65 years) using either four or more chronic medications or one or more medications associated with an increased risk of falling (n = 10,565) | ||
520 | |a INTERVENTION: Pharmacy staff screened patients for fall risk using questions from the Stopping Elderly Accidents, Deaths, and Injuries (STEADI) algorithm. Patients who screened positive were eligible to receive a pharmacist-conducted medication review, with recommendations sent to patients' healthcare providers following the review | ||
520 | |a MEASUREMENTS: At intervention pharmacies, pharmacy staff used standardized forms to record participant responses to screening questions and information concerning the medication reviews. For participants with continuous Medicare Part D/NC Medicaid coverage (n = 3,212), the Drug Burden Index (DBI) was used to assess exposure to high-risk medications, and insurance claims records for emergency department visits and hospitalizations were used to assess falls | ||
520 | |a RESULTS: Among intervention group participants (n = 4,719), 73% (n = 3,437) were screened for fall risk. Among those who screened positive (n = 1,901), 72% (n = 1,373) received a medication review; and 27% (n = 521) had at least one medication-related recommendation communicated to their healthcare provider(s) following the review. A total of 716 specific medication recommendations were made. DBI scores decreased from the pre- to postintervention period in both the control and the intervention group. However, the amount of change over time did not differ between these two groups (P = .66). Risk of falling did not change between the pre- to postintervention period or differ between groups (P = .58) | ||
520 | |a CONCLUSION: We successfully implemented STEADI-Rx in the community pharmacy setting. However, we found no differences in fall risk or the use of medications associated with increased risk of falling between the intervention and control groups. J Am Geriatr Soc 68:1778-1786, 2020 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
650 | 4 | |a Research Support, U.S. Gov't, P.H.S. | |
650 | 4 | |a aging | |
650 | 4 | |a community pharmacy | |
650 | 4 | |a falls | |
650 | 4 | |a health services | |
650 | 4 | |a medication | |
700 | 1 | |a Ferreri, Stefanie P |e verfasserin |4 aut | |
700 | 1 | |a Renfro, Chelsea P |e verfasserin |4 aut | |
700 | 1 | |a Robinson, Jessica M |e verfasserin |4 aut | |
700 | 1 | |a Farley, Joel F |e verfasserin |4 aut | |
700 | 1 | |a Ray, Neepa |e verfasserin |4 aut | |
700 | 1 | |a Busby-Whitehead, Jan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Geriatrics Society |d 1953 |g 68(2020), 8 vom: 21. Aug., Seite 1778-1786 |w (DE-627)NLM000041769 |x 1532-5415 |7 nnns |
773 | 1 | 8 | |g volume:68 |g year:2020 |g number:8 |g day:21 |g month:08 |g pages:1778-1786 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/jgs.16459 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 68 |j 2020 |e 8 |b 21 |c 08 |h 1778-1786 |